← Leaderboards
Naomi Hunder
University Of Washington
$9,173
Attributed
$9,173
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7.4K · FY2005–07$10K$7.5K$5K$2.5K$0
'05
'06
'07
Funding mix
By agency
NIH$9,173 · 2
By mechanism
M01$9,173 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Philip D Greenberg$22,941,903
- Kristin R Swanson$9,657,765
- Mary L. Disis$210,448,010
- Ann Cornwall Collier$29,777,747
- Andre Michael Lieber$20,253,196
Others in their field
Top investigators on “Antigens”
- Barton F Haynes · Duke University$488,918,563
- Lawrence Corey · Fred Hutchinson Cancer Center$325,880,100
- Dennis R. Burton · Scripps Research Institute$291,395,948
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$245,204,950
- Jeffrey P Krischer · University Of South Florida$208,289,343
- Dan H. Barouch · Fred Hutchinson Cancer Center$124,506,327
Research focus
AntigensAntitumor ResponseBaseBlood SpecimenCa-125 AntigenCd4 Positive T LymphocytesCd8b1 GeneCd8-Positive T-LymphocytesChemotherapyClinical TrialsComputer Retrieval Of Information On Scientific Projects DatabaseCtag1 GeneDoseEarly TreatmentFundingGrantImageImmuneImmunotherapy, AdoptiveInfusion ProceduresInstitutionLeukapheresisMalignant Neoplasm Of OvaryMaximum Tolerated Dose
Grant awards (3)
PHASE I STUDY TO EVALUATE THE SAFETY OF CELLULAR ADOPTIVE IMMUNOTHERAPY$303
M01 · FY2007 · RR · contact PI
PHASE I STUDY TO EVALUATE THE SAFETY OF CELLULAR ADOPTIVE IMMUNOTHERAPY$7,443
M01 · FY2006 · RR · contact PI
PHASE I STUDY TO EVALUATE THE SAFETY OF CELLULAR ADOPTIVE IMMUNOTHERAPY$1,427
M01 · FY2005 · RR